Erratum: Enhancement of the in vivo persistence and antitumor efficacy of CD19 chimeric antigen receptor T cells through the delivery of modified TERT mRNA. uri icon

Overview

abstract

  • [This corrects the article DOI: 10.1038/celldisc.2015.40.].

publication date

  • January 26, 2016

Identity

PubMed Central ID

  • PMC4860956

Scopus Document Identifier

  • 85034854078

Digital Object Identifier (DOI)

  • 10.1038/celldisc.2015.52

PubMed ID

  • 27462841

Additional Document Info

volume

  • 2